Last reviewed · How we verify
Vitiligo
Approved treatments
- Trisoralen
- Oxsoralen-Ultra · Bausch Health
Oxsoralen-Ultra works by generating free radicals when exposed to ultraviolet A (UVA) light, which helps to slow down the growth of skin cells and reduce inflammation. - Jakafi · Incyte Corp
Pipeline
- PF-07038124 · Pfizer Inc. — Phase 2
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vitiligo patent landscape — cliff calendar, originator estates, attackable patents
- Vitiligo treatment landscape brief
- Vitiligo treatment updates RSS
Frequently asked questions about Vitiligo
What drugs treat Vitiligo?
Tracked treatments include Trisoralen, Oxsoralen-Ultra, Jakafi.
What is the treatment for Vitiligo?
Standard treatment for Vitiligo includes Trisoralen, Oxsoralen-Ultra, Jakafi. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Vitiligo?
1 pipeline drugs tracked. Top candidates: PF-07038124.
Related
- Treatment landscape: Vitiligo patent cliff · Vitiligo CI report
- Treatment: Trisoralen
- Treatment: Oxsoralen-Ultra · Bausch Health
- Treatment: Jakafi · Incyte Corp
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing